MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
259 hedge funds and large institutions have $8.33B invested in Mirati Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 104 increasing their positions, 65 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
7% less funds holding in top 10
Funds holding in top 10: 15 → 14 (-1)
13% less capital invested
Capital invested by funds: $9.58B → $8.33B (-$1.24B)
Holders
259
Holding in Top 10
14
Calls
$108M
Puts
$53M
Top Buyers
| 1 | +$70.4M | |
| 2 | +$55.9M | |
| 3 | +$44.2M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$43M |
| 5 |
Holocene Advisors
New York
|
+$36.4M |
Top Sellers
| 1 | -$82.1M | |
| 2 | -$49.9M | |
| 3 | -$43M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$42.8M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$42.2M |